Restoring Balance

FirstString Research Is Committed To Developing Transformative Therapeutics For Inflammation And Injury Based Medical Conditions.

FirstString Research is a clinical stage biopharmaceutical company developing dermatologic, ophthalmic, organ preservation, and pulmonary therapeutics utilizing our proprietary aCT1 technology platform. We are dedicated to developing drugs that will enable physicians to better manage a variety of indications involving inflammation and the body’s response to injury.